According to the new market research report ECG Market is expected to reach USD 10.3 billion by 2024 from USD 7.5 billion in 2019, at a CAGR of 6.4% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173
Factors
such as the rising incidence of lifestyle & cardiovascular diseases
and increasing geriatric population are expected to propel the growth
of the diagnostic electrocardiograph market.
Asia Pacific diagnostic ECG market is expected to grow at the highest CAGR during the forecast period
On
the basis of region, the diagnostic ECG market is segmented into North
America, Europe, Asia Pacific, and RoW. The Asia Pacific is expected to
grow at the highest CAGR during the forecast period. Factors such as
growth in the geriatric population, growing incidence of chronic
diseases, rising healthcare spending, healthcare reforms for
infrastructural development, growing demand for advanced technologies,
and less stringent regulations are fueling the demand for diagnostic ECG
products and services in this region.
PERSONALIZE THIS RESEARCH
> Triangulate with your Own Data
> Get Data as per your Format and Definition
> Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
> Any level of Personalization
Get 10% FREE Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=173
The 3-lead ECG segment is expected to grow at the highest CAGR in the diagnostic ECG market during the forecast period
By
lead type, the diagnostic ECG market is divided into 12-lead, 5-lead,
3-lead, 6-lead, single-lead, and other lead types (15- and 18-lead). The
3-lead segment is expected to grow at the highest CAGR during the
forecast period. This positive growth is primarily due to the fact that
these leads are used conjointly with various other cardiac diagnostic
tests and during medical procedures.
The hospitals, clinics, and
cardiac centers segment accounted for the largest share of the
diagnostic electrocardiograph market in 2018
By end user, the
market is classified into hospitals, clinics, and cardiac centers;
ambulatory surgical centers; and other end users. In 2018, the
hospitals, clinics, and cardiac centers segment accounted for the
largest share of the market. The large share of this segment can
primarily be attributed to the growing burden of cardiovascular
diseases, which, in turn, is increasing the need for quality cardiology
care.
The ECG market is dominated by players such as GE
Healthcare (US), Philips Healthcare (Netherlands), Nihon Kohden (Japan),
Hill-Rom Holdings (US), and Ambu (Denmark).
Get report sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=173